253 related articles for article (PubMed ID: 12124174)
1. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma.
Liu D; Aguirre Ghiso J; Estrada Y; Ossowski L
Cancer Cell; 2002 Jun; 1(5):445-57. PubMed ID: 12124174
[TBL] [Abstract][Full Text] [Related]
2. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.
Aguirre-Ghiso JA; Liu D; Mignatti A; Kovalski K; Ossowski L
Mol Biol Cell; 2001 Apr; 12(4):863-79. PubMed ID: 11294892
[TBL] [Abstract][Full Text] [Related]
3. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.
Aguirre Ghiso JA; Kovalski K; Ossowski L
J Cell Biol; 1999 Oct; 147(1):89-104. PubMed ID: 10508858
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo.
Aguirre Ghiso JA
Oncogene; 2002 Apr; 21(16):2513-24. PubMed ID: 11971186
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
Yebra M; Goretzki L; Pfeifer M; Mueller BM
Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
[TBL] [Abstract][Full Text] [Related]
6. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.
Guerrero J; Santibañez JF; González A; Martínez J
Exp Cell Res; 2004 Jan; 292(1):201-8. PubMed ID: 14720519
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor.
Jo M; Thomas KS; O'Donnell DM; Gonias SL
J Biol Chem; 2003 Jan; 278(3):1642-6. PubMed ID: 12426305
[TBL] [Abstract][Full Text] [Related]
8. Gangliosides inhibit urokinase-type plasminogen activator (uPA)-dependent squamous carcinoma cell migration by preventing uPA receptor/alphabeta integrin/epidermal growth factor receptor interactions.
Wang XQ; Sun P; Paller AS
J Invest Dermatol; 2005 Apr; 124(4):839-48. PubMed ID: 15816844
[TBL] [Abstract][Full Text] [Related]
9. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling.
Wei Y; Yang X; Liu Q; Wilkins JA; Chapman HA
J Cell Biol; 1999 Mar; 144(6):1285-94. PubMed ID: 10087270
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
[TBL] [Abstract][Full Text] [Related]
11. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA
Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185
[TBL] [Abstract][Full Text] [Related]
12. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator receptor regulates a novel pathway of fibronectin matrix assembly requiring Src-dependent transactivation of epidermal growth factor receptor.
Monaghan-Benson E; McKeown-Longo PJ
J Biol Chem; 2006 Apr; 281(14):9450-9. PubMed ID: 16461772
[TBL] [Abstract][Full Text] [Related]
14. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
Aguirre-Ghiso JA; Estrada Y; Liu D; Ossowski L
Cancer Res; 2003 Apr; 63(7):1684-95. PubMed ID: 12670923
[TBL] [Abstract][Full Text] [Related]
15. Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway.
Liu Y; Pixley R; Fusaro M; Godoy G; Kim E; Bromberg ME; Colman RW
Oncogene; 2009 Jul; 28(30):2756-65. PubMed ID: 19483730
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside GM3 blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites.
Wang XQ; Sun P; Paller AS
J Biol Chem; 2003 Dec; 278(49):48770-8. PubMed ID: 14512423
[TBL] [Abstract][Full Text] [Related]
17. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Eur J Biochem; 2002 Aug; 269(16):3945-57. PubMed ID: 12180971
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
19. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator receptor crosslinking in an NK cell line increases integrin surface expression by the MAP kinase/ERK 1/2 signaling pathway.
Gellert GC; Kitson RP; Goldfarb RH
J Cell Biochem; 2003 May; 89(2):279-88. PubMed ID: 12704791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
